Ocean Biomedical, Inc.
OCEA
$0.04
-$0.0015-3.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.75M | 768.00K | 682.00K | 569.00K | -643.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.75M | 768.00K | 682.00K | 595.00K | -660.00K |
| Operating Income | -1.75M | -768.00K | -682.00K | -595.00K | 660.00K |
| Income Before Tax | 283.00K | -5.53M | -17.23M | 13.00M | -16.86M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 283.00K | -5.53M | -17.23M | 13.00M | -16.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 283.00K | -5.53M | -17.23M | 13.00M | -16.86M |
| EBIT | -1.75M | -768.00K | -682.00K | -595.00K | 660.00K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.01 | -0.20 | -0.63 | 0.48 | -0.62 |
| Normalized Basic EPS | 0.01 | -0.13 | -0.39 | 0.30 | -0.39 |
| EPS Diluted | 0.01 | -0.20 | -0.63 | 0.48 | -0.62 |
| Normalized Diluted EPS | 0.01 | -0.13 | -0.39 | 0.30 | -0.39 |
| Average Basic Shares Outstanding | 27.67M | 27.49M | 27.49M | 27.34M | 27.23M |
| Average Diluted Shares Outstanding | 27.67M | 27.49M | 27.49M | 27.34M | 27.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |